SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is trending with intense community discussion, as many are actively accumulating and viewing current price levels as a significant buying opportunity. The token's identity as the "Face of Base" and its potential for a substantial rally are key talking points, fueled by a broader bullish crypto market and anticipation of regulatory clarity. Speculation around potential major exchange listings and recent engagement from key industry figures are also driving conversations among holders.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is a focal point of intense market and political discussion following reports of statements concerning Greenland and potential new tariffs on European nations. The community is actively debating the implications of these proposals, with some viewing them as strategic moves for national security and others expressing strong concerns about potential global trade disruptions, instability within NATO, and broader economic repercussions.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending as it unveils significant quantum computing advancements, including its Nighthawk processor, and strengthens its enterprise AI and hybrid cloud strategy through a major acquisition and collaboration with Cisco on quantum networking. The community highlights IBM's established position in cutting-edge technology and consistent analyst upgrades, seeing it as a compelling, undervalued leader in the evolving tech landscape.

City Holding Co. is a financial holding company, which engages in the provision of financial and community banking services. Its products produced and services rendered by City National include Commercial Banking, Consumer Banking, Mortgage Banking, and Wealth Management and Trust Services. The company was founded on March 12, 1982 and is headquartered in Charleston, WV.

City Holding Co.

City Holding (CHCO) is actively discussed following its latest earnings report, where a slight miss on expectations is being weighed against management's positive outlook on fundamental strength and a recent acquisition. Community sentiment appears mixed, with some investors emphasizing the regional bank's consistent performance and dividend history, while others are noting recent insider selling and technical signals suggesting a downtrend. The conversation reflects ongoing evaluation of CHCO's strategic growth and resilience within the broader banking environment.

Marine Products Corp. engages in the design, manufacture, and sale of fiberglass powerboats through its subsidiary. Its products include Vortex, Robalo, and Chaparral. The company was founded on August 31, 2000 and is headquartered in Atlanta, GA.

Marine Products Corp

Marine Products Corp. is trending after recent financial results revealed a continued downturn across the marine industry, marked by significant declines in sales and earnings. The community is actively debating whether the company's sustained dividend payout reflects strategic capital preservation amidst challenges, or if it delays confronting persistent macro-economic headwinds like high inventory and interest rates. While management adjusts production conservatively, some investors point to strong fundamentals and anticipate a potential sector stabilization.

Covenant Logistics Group, Inc. is a holding company, which engages in the provision of freight and logistics services. It operates through the following segments: Highway Services and Dedicated Contract Services. The Highway Services Segment includes two separate service offerings: Expedited Services (Expedited) and Over-the-Road Services (OTR), both of which transport one-way freight over non-routine routes. The Dedicated Contract Services Segment provides similar transportation services, but does so pursuant to agreements whereby equipment available to a specific customer for shipments over particular routes at specified times. The company was founded by David Ray Parker in 1986 and is headquartered in Chattanooga, TN.

Covenant Logistics Group Inc - Ordinary Shares - Class A

Covenant Logistics Group is actively discussed following its recent Q4 earnings, where adjusted EPS aligned with expectations despite a slight revenue miss. Community conversations are focused on the impact of trucking market normalization and cost inflation, balanced against the company's strategic initiatives to grow its dedicated fleet. The recent 2-for-1 stock split and move to the NYSE also continue to draw significant investor interest in the industrial transportation sector.

World Acceptance Corp. engages in the small-loan consumer finance business. It offers short-term small instalment, medium-term larger loans, related credit insurance, ancillary products and services to individuals. The firm also offers income tax return preparation services to customers. The company also markets computer software and related services to financial services companies through its subsidiary, ParaData Financial Systems. It operates in the following segments: Small Loans, Large Loans, and Tax Advance Loans. World Acceptance was founded in 1962 and is headquartered in Greenville, SC.

World Acceptance Corp.

World Acceptance Corp. (WRLD) is trending following a significant earnings beat, which has sparked a bullish sentiment among some investors. The community is actively discussing the company's operational focus on credit quality and strategic shift to medium-term loans, though some express caution regarding the consumer finance sector's resilience in the current economic landscape.

Invesco Ltd. engages in the investment management business. Its products include mutual funds, unit trusts, exchange-traded funds, closed-end funds, and retirement plans. The company was founded in December 1935 and is headquartered in Atlanta, GA.

Invesco Ltd

Invesco is trending following shareholder approval for the reclassification of the flagship QQQ ETF into an open-end structure, a move widely expected to significantly enhance fee income and attract greater investor inflows. The community is actively discussing this "QQQ shake-up" and its potential for long-term growth, alongside recent robust Assets Under Management increases driven by strong net inflows and strategic expansion into private markets.

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Erasca Inc

Erasca (ERAS) is actively trending as a sympathy play amid M&A speculation surrounding its peer Revolution Medicines, drawing attention to ERAS's own pipeline of RAS/MAPK pathway-driven cancer therapies. The community is discussing its long-term potential, citing recent analyst upgrades, institutional accumulation, and a robust cash runway, positioning it as a significant player in the evolving oncology acquisition landscape.

Automatic Data Processing, Inc. engages in the provision of business outsourcing solutions in cloud-based human capital management. It operates through the following business segments: Employer Services, Professional Employer Organization Services, and Other. The Employer Services segment provides clients from single-employee small businesses to large enterprises offering human resources outsourcing and technology-based human capital management solutions and cloud-based platforms. The Professional Employer Organization Services segment offers small and mid-sized businesses a human resource outsourcing solution through a co-employment mode. The Other segment includes the certain corporate overhead charges and expenses that have not been allocated to the reportable segments. The company was founded by Henry Taub in 1949 and is headquartered in Roseland, NJ.

Automatic Data Processing Inc.

Automatic Data Processing (ADP) is currently trending due to recent analyst downgrades, notably to Underperform from Jefferies, signaling caution amidst an evolving labor market. The community is actively debating ADP's resilience as a "business necessity" and dividend payer against concerns over slowing job growth and the potential disruptive impact of AI on HR services. Many view ADP as a key indicator for broader economic health, making its performance a focal point as investors assess future hiring trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Schwab Fundamental International Equity ETF (FNDF) a Strong ETF Right Now?

Here's Why You Should Build a Global Portfolio With ETFs 

Despite slowing growth, global equities are showing renewed strength. Discover how a globally diversified ETF portfolio can help investors build more balanced, opportunity-ready portfolios.

Should You Look Abroad? Global Equity ETFs to Consider

Stretched U.S. valuations and AI bubble fears have investors looking abroad and are driving interest in international equity and emerging market ETFs.

Global Equity ETFs Draw Rising Investor Interest

Global equity funds saw $10.65B inflows as Fed rate cut bets, a weak dollar and diversification needs drive investors abroad.

Is JPMorgan Diversified Return International Equity ETF (JPIN) a Strong ETF Right Now?

Is Vident International Equity Strategy ETF (VIDI) a Strong ETF Right Now?

Is ALPS International Sector Dividend Dogs ETF (IDOG) a Strong ETF Right Now?

U.S.-listed shares of BioNTech SE ended Monday nearly 3.2% lower, weighed down by a weak full-year revenue projection even as the German drugmaker posted a quarterly earnings beat. Retail traders, however, did not appear too shaken.Fourth-quarter revenue fell to 1.19 billion euros ($1.29 billion) from 1.48 billion euros a year earlier — as demand for COVID-19 vaccines shrank — but was better than Wall Street's estimate of 1.09 billion euros.&nbsp;Likewise, Q4 earnings per share (EPS) fell to 1.08 euros from 1.88 euros a year earlier but easily topped a consensus estimate of 0.41 euros.&nbsp;The company said clinical studies for late-stage oncology candidates raised research and development (R&amp;D) expenses by nearly 6%.For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros. The bulk of the sales are expected to come in the final quarter of 2025.The outlook factors in stable vaccination trends, Pfizer-related inventory write-downs, revenue from Germany's pandemic preparedness deal, and BioNTech's service businesses.The company anticipates full-year R&amp;D costs rising to 2.6 billion euros to 2.8 billion euros from 2.25 billion euros in 2024, primarily due to late-stage development and commercial readiness in oncology.Following the results, BofA Securities lowered its price target on BioNTech to $143 from $147 but kept a 'Buy' rating on the shares, noting that 2024 COVID-19 revenue was higher than consensus estimates.However, the research firm flagged potential vaccination policy risks in the U.S. and other regions, saying it would monitor trends in 2025 while remaining optimistic about BioNTech's oncology pipeline, which includes over 20 late-stage trials. Multiple data readouts are expected this year and next.On Stocktwits, sentiment for BioNTech ended on a 'bullish' note on Monday amid a 600% spike in message volume, with shares climbing after the closing bell.<figure class="image"><img style="aspect-ratio:1316/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BNTX_sentiment_and_message_volume_as_of_March_10_2c73debe23.png" alt="BNTX sentiment and message volume as of March 10.png" width="1316" height="302"><figcaption>BNTX sentiment and message volume as of March 10 | source: Stocktwits</figcaption></figure>Amid some cautiousness over BioNTech's cash burn, optimistic watchers pinned hopes on the company's oncology pipeline and relatively cheap valuation.&nbsp;<stembedurl>https://stocktwits.com/Robert321/message/607415401</stembedurl><stembedurl>https://stocktwits.com/taxplanr/message/607554091</stembedurl>BioNTech trades at a forward enterprise value-to-sales ratio multiple of 2.5, compared to Pfizer's 3.1 and Eli Lilly &amp; Co's 13.1.Shares are down over 8% this year but have gained 15.6% in the past 12 months.BioNTech stock trades 38% below the average price target of $145.54 set by 21 Wall Street analysts. Of these, 12 rate it a 'Buy,' five a 'Strong Buy,' and four a 'Hold,' according to Koyfin data.(1 euro=$1.08)For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BioNTech logo is displayed on a smartphone screen. (Photo illustration by Cheng Xin/Getty Images)

BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic

For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.

FNDF
Schwab Strategic Trust - Schwab Fundamental International Large Company Index ETF

Feed

News

Sentiment

Fundamentals

Info

Latest FNDF News

FNDFSchwab Strategic Trust - Schwab Fundamental International Large Company Index ETF